melanomarGBMrenal cancersRecurrent glioblastomapembrolizumabbevacizumab-naïvebevacizumab-refractorydexamethasone
…es, activity in rGBM has been disappointing. Emerging data from melanoma, lung, and renal cancers suggest that treatment-induced or dise…